| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-12 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |